Overview
Prof. Rama Rao Malla, a biochemistry researcher at the GITAM University, is heading a three‑year project to develop a minimally invasive blood test for early detection of TNBC. The work is funded by the ICMR under its "Follow‑on Nischayak Anveshan" Extramural Grants programme, with a budget of over ₹2 crore.
Key Developments
- Establishment of a dedicated cancer research laboratory at GITAM in 2011.
- Guidance of 14 doctoral scholars and completion of multiple breast‑cancer projects.
- Current focus on identifying serum exosomal microRNAs as early‑stage TNBC markers.
- Use of next‑generation sequencing, digital PCR, and a machine‑learning model to differentiate patients from healthy controls.
- Goal to translate findings into a kit‑based diagnostic test within three years.
Important Facts
TNBC lacks receptors for estrogen, progesterone and HER2, making chemotherapy the primary treatment. However, many patients develop drug resistance. Early detection is crucial because mammography often misses small tumours in younger women (mid‑30s to 40s). The research will compare serum samples from early‑stage TNBC patients at the Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI) and GITAM Institute of Medical Sciences and Research (GIMSR) with those from healthy women.
Exam Relevance
The project illustrates the intersection of science‑policy linkage (ICMR funding), healthcare innovation (early cancer diagnostics), and technology adoption (machine‑learning). Aspirants should note:
- How central research bodies like ICMR shape national health priorities (GS3: Health).
- The role of universities in translating research into public health tools (GS2: Polity).
- Implications for India’s cancer burden and the need for affordable diagnostics (GS1: Health, GS3: Economy).
Way Forward
To maximise impact, the team should:
- Validate identified microRNA signatures across larger, multi‑regional cohorts.
- Engage with the Ministry of Health and Family Welfare for regulatory approval pathways.
- Explore public‑private partnerships to scale kit production and ensure affordability.
- Integrate the test into existing breast‑cancer screening programs, especially in rural health centres.
Successful completion will provide a low‑cost, early‑diagnosis tool, potentially reducing mortality from TNBC and showcasing India’s capacity for cutting‑edge biomedical research.